These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30096922)

  • 1. Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release.
    Ruhe J; Waldeyer C; Ojeda F; Altay A; Schnabel RB; Schäfer S; Lackner KJ; Blankenberg S; Zeller T; Karakas M
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30096922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study.
    Weidmann H; Bannasch JH; Waldeyer C; Shrivastava A; Appelbaum S; Ojeda-Echevarria FM; Schnabel R; Lackner KJ; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 May; 9(9):e015480. PubMed ID: 32321351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study).
    Grammer TB; Scharnagl H; Dressel A; Kleber ME; Silbernagel G; Pilz S; Tomaschitz A; Koenig W; Mueller-Myhsok B; März W; Strnad P
    Clin Chem; 2019 Jul; 65(7):849-861. PubMed ID: 30917972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study.
    Zeller T; Altay A; Waldeyer C; Appelbaum S; Ojeda F; Ruhe J; Schnabel RB; Lackner KJ; Blankenberg S; Karakas M
    Biomolecules; 2018 Jun; 8(3):. PubMed ID: 29958400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure.
    Jankowska EA; Kasztura M; Sokolski M; Bronisz M; Nawrocka S; Oleśkowska-Florek W; Zymliński R; Biegus J; Siwołowski P; Banasiak W; Anker SD; Filippatos G; Cleland JG; Ponikowski P
    Eur Heart J; 2014 Sep; 35(36):2468-76. PubMed ID: 24927731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
    Drakou A; Margeli A; Theodorakopoulou S; Agrogiannis I; Poziopoulos C; Papassotiriou I; Vlahakos DV
    Blood Cells Mol Dis; 2016 Jul; 59():100-5. PubMed ID: 27282576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
    Grammer TB; Kleber ME; Silbernagel G; Pilz S; Scharnagl H; Tomaschitz A; König W; März W
    Atherosclerosis; 2014 Oct; 236(2):292-300. PubMed ID: 25112800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome.
    Zeller T; Waldeyer C; Ojeda F; Schnabel RB; Schäfer S; Altay A; Lackner KJ; Anker SD; Westermann D; Blankenberg S; Karakas M
    Biomolecules; 2018 Jul; 8(3):. PubMed ID: 30037035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.
    Ndrepepa G; Braun S; Dibra A; Mehilli J; Vogt W; Schömig A; Kastrati A
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):418-25. PubMed ID: 16314228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations.
    Braun S; Ndrepepa G; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Atherosclerosis; 2004 May; 174(1):105-10. PubMed ID: 15135258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin and iron metabolism associated with cardiometabolic risk factors in children: A case-control study.
    Zhu YN; He BT; Jing J; Ma J; Li XH; Yang WH; Jin Y; Chen YJ
    Nutr Metab Cardiovasc Dis; 2016 Jun; 26(6):525-33. PubMed ID: 27139516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron status and survival in diabetic patients with coronary artery disease.
    Ponikowska B; Suchocki T; Paleczny B; Olesinska M; Powierza S; Borodulin-Nadzieja L; Reczuch K; von Haehling S; Doehner W; Anker SD; Cleland JG; Jankowska EA
    Diabetes Care; 2013 Dec; 36(12):4147-56. PubMed ID: 24130349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor analysis of risk variables associated with iron status in patients with coronary artery disease.
    Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Kalimanovska-Ostric D; Memon L; Spasic S; Kotur-Stevuljevic J; Jelic-Ivanovic Z
    Clin Biochem; 2014 May; 47(7-8):564-9. PubMed ID: 24690216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm.
    Martinez-Pinna R; Lindholt JS; Madrigal-Matute J; Blanco-Colio LM; Esteban-Salan M; Torres-Fonseca MM; Lefebvre T; Delbosc S; Laustsen J; Driss F; Vega de Ceniga M; Gouya L; Weiss G; Egido J; Meilhac O; Michel JB; Martin-Ventura J
    Thromb Haemost; 2014 Jul; 112(1):87-95. PubMed ID: 24599423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
    Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
    Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.
    Shalitin S; Deutsch V; Tauman R
    J Endocrinol Invest; 2018 Aug; 41(8):969-975. PubMed ID: 29305826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.